SOURCE: HolGenTech


January 18, 2010 08:27 ET

HolGenTech to Demo Genome Based Prevention Model in Hand-Held Personal Genome Assistant at Personalized Medicine World Conference

'Shop for Your Life' YouTube Demo Features Consumer Prevention Tool for the New Health Paradigm: Ask What You Can Do for Your Genome!

MOUNTAIN VIEW, CA--(Marketwire - January 18, 2010) - HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention. HolGenTech will present on stage, Room E, on Tuesday, January 19, at 11:30 am PT and throughout the conference in the HolGenTech booth. See the YouTube of the HolGenTech PGA demonstration: "Shop for Your Life."

The PGA uses a device's bar code reader to capture product ingredient information and respond with personalized screens of recommendation advice and ratings that display on a scale of -10 to +10, corresponding to analysis of integrated data from multiple sources. The PGA user can automatically and immediately identify the personalized prevention efficacy of any product under consideration, as long as the product has a bar code for ingredients. Consumers are equipped to make quick, yet thorough, product comparisons that take into consideration personal health preferences and genomic information with special attention to a disease, syndrome, or health condition they wish to improve.

"A Genome Based Economy is upon us. Soon, awareness of our genome will allow us to use our genome to live in a way that constantly promotes personal health and well being. As we are aware of our genome, we realize that the genome is not our destiny, but rather it is affected by our choices. In the HolGenTech genome computing architecture we perform the analysis and provide the user tools to discover and make the best genomic and personal choices," said HolGenTech founder Dr. Andras Pellionisz. "Through the HolGenTech genome computing architecture, we can provide answers as consumers respond to the compelling new paradigm and its imperative: Ask what you can do for your genome!"

The HolGenTech PGA illustrates the practical application of the genome, emphasizing how personal genome analysis can be used as a tool for an individual to pursue all they can do to affect their genome. Disease prevention -- or health -- hinges on optimizing epigenomic pathways through foods, food additives, vitamins, cosmetics, chemicals, and environments to best fit or fix one's genome. The HolGenTech genome computing architecture -- where the PGA represents a mobile component -- utilizes high performance parallel computing for genome analysis to search for both conventional structural variants and proprietary search of fractal defects, making the genome practically usable for consumers who want to make their best choices for living.

HolGenTech will feature its genome computing architecture in demonstrations of the PGA mobile application and the Personal Genome Computer (PGC). Also featured will be a mobile application for Alzheimer patient tracking, ALZtrek, which utilizes a smartphone's GPS to track the whereabouts of early stage Alzheimer patients.

Visit HolGenTech booth at PMWC 2010. See the YouTube of the HolGenTech PGA demonstration: "Shop for Your Life."

About HolGenTech

HolGenTech leads the way in accelerating genome computing analysis with software addressing the applications for a Genome Based Economy. The Silicon Valley based company was founded on the basis of HoloGenomics: the synthesis of Genomics and Epigenomics expressed in Informatics calling for novel architectures of genome computing. The company is currently engaged in securing Series A or angel funding for a rapid ignition to ramp up implementation of the genome computing architecture.

Contact Information

  • Contact:
    Suzanne Matick
    Media and Investor Relations
    Email Contact